LGND
You've reached a level of minutia that my mind and even website lacks, but probably is in my files somewhere. But from memory, I believe the SGP-PCOP deal would have involved SGP gaining rights to screen PCOP's chemical library for potential inhibitors of a list of targets of interest. If that is the case, I would feel strongly about single digits, but I am not sure without further digging
Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.